AG
PARN

Artal Group’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Artal Group’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-500,000
Closed -$1.06M – 82
2016
Q1 		$1.06M Hold
500,000
– – 0.02% 57
2015
Q4 		$1.94M Hold
500,000
– – 0.04% 75
2015
Q3 		$1.72M Hold
500,000
– – 0.04% 69
2015
Q2 		$2.48M Hold
500,000
– – 0.11% 63
2015
Q1 		$2.46M Hold
500,000
– – 0.11% 68
2014
Q4 		$2.08M Hold
500,000
– – 0.07% 81
2014
Q3 		$2.88M Buy
+500,000
New +$3.01M 0.11% 77

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Artal Group's PARN Position: Q2 2016 in Review

Artal Group sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q2 2016, closing a stake of 500,000 shares — an estimated $1.06M sold.

Artal Group first reported a position in PARN in Q3 2014 and held it in 7 quarters. The position peaked at $2.88M in Q3 2014. 19 funds tracked by Wall St. Rank hold PARN as of Q2 2016.

  • Artal Group reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q2 2016 after selling out during the quarter.
  • Artal Group sold 500,000 Parnell Pharmaceuticals Holdings Ltd shares in Q2 2016, an estimated $1.06M.
  • Artal Group first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and held it in 7 quarters.
  • Artal Group's Parnell Pharmaceuticals Holdings Ltd position peaked at $2.88M in Q3 2014.
  • 19 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q2 2016.

Based on Artal Group's 13F filing for Q2 2016, filed 11 Aug 2016.